Antiarrhythmic drugs: new agents and evolving concepts.
Properties of several new antiarrhythmic drugs are summarised in this review article. Recent concepts concerning their safety and efficacy of antiarrhythmics are discussed. A brief perspective on possible future strategies for pharmacotherapy of arrhythmias is provided.
Nemec
Jan
J
2nd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, U nemocnice 2, Praha 2, 128 00, Czech Republic.
Shen
Win-Kuang
WK
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D002986:Clinical Trials as Topic; D015316:Genetic Therapy; D006325:Heart Atria / Q000187:drug effects; D006801:Humans; D007473:Ion Channels / Q000037:antagonists & inhibitors; D010597:Pharmacogenetics; D044140:Receptor, Angiotensin, Type 1
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D007473:Ion Channels; D044140:Receptor, Angiotensin, Type 1